Fabricante de pó de esteróides anabolizantes na China
EnglishAfrikaansБългарскиNederlandsFrançaisDeutschItaliano日本語LatīnaNorskپارسیPolskiPortuguêsRomânăРусскийSlovenčinaSlovenščinaEspañolSvenskaTürkçeУкраїнська

Peptídeos Farmacêuticos

» Peptídeos » Peptídeos Farmacêuticos

  • Especificações
  • Descrição do produto
  • Uso do produto
  • COA
Nome do produto Triptorelin Acetate
Nº CAS. 140194-24-7
MF C64H82N18O13
PM 1311.45
EINECS NÃO. N / D
Pureza 99%
Aparência White freeze dried powder
Armazenar Store at -20°C

Triptorelin is a gonadotropin-releasing hormone agonist used as the acetate or pamoate salts. By causing constant stimulation of the pituitary, it decreases pituitary secretion of gonadotropins luteinizing hormone and follicle stimulating hormone. Like other GnRH agonists, triptorelin may be used in the treatment of hormone-responsive cancers such as prostate cancer or breast cancer, precocious puberty, estrogen-dependent conditions, and in assisted reproduction. Triptorelin is marketed under the brand names Decapeptyl and Diphereline and Gonapeptyl.

Triptorelin,a decapeptide (pGlu-His-Trp-Ser-Tyr-D-Trp-Leu-Arg-Pro-Gly-NH2), is a gonadotropin-releasing hormone agonist (GnRH agonist) used as the acetate or pamoate salts. By causing constant stimulation of the pituitary, it decreases pituitary secretion of gonadotropins luteinizing hormone (ES) and follicle stimulating hormone (FSH). Like other GnRH agonists, triptorelin may be used in the treatment of hormone-responsive cancers such as prostate cancer or breast cancer, precocious puberty, estrogen-dependent conditions (such as endometriosis or uterine fibroids), and in assisted reproduction. It is also used as therapy in cases of gender dysphoria.

Triptorelin is a GNRH agaonist shown to inhibit estradiol-induced cancer cell proliferationIn vivo.

1. Triptorelin can improve the pregnancy rate by 12% para 15% in ewes6 and downregulate ovarian GNRHR-I expression of female rats, especially in late-growing follicles.

2. Triptorelin immunity blocked EET and UWT, inhibited uterine growth and development and enhance the expression levels s of ESR1, LHR, and FSHR proteins.

3. Triptorelin may be used in the treatment of hormone-responsive cancers such as breast cancer or prostate cancer, precocious puberty, estrogen-dependent conditions, and assisted reproduction.

Impureza Única (HPLC): 1.0%máx.
Composição de aminoácidos: ±10% do teórico
Conteúdo Peptídico (N%): ≥80,0%
Conteúdo de água(Carlos Fischer): ≤6.0%
Triptorelin Acetate Acetate Content (HPIC): ≤15,0%
Triptorelin Acetate MS(ESI): Consistente
Triptorelin Acetate Mass Balance: 95.0~105,0%
Triptorelin Acetate Specific Rotation (20/D): -65.0~-75.0°(c=0.5 1%HAc)

Formulário de consulta ( retornaremos o mais rápido possível )

Nome:
*
E-mail:
*
Mensagem:

Verificação:
5 + 5 = ?

Talvez você também goste

  • Nossa vantagem

    Bom preço

    Alta qualidade

    Entrega rápida

    Remessa Segura

    Excelente serviço pós-venda

  • Armazém Local

    Armazém da UE

    Armazém no Reino Unido

    Armazém dos EUA

    Armazém Canadá

    Armazém Austrália

  • Método de pagamento

    PayPal

    Bitcoin

    Transferência Bancária

    Grama de dinheiro

    Western Union

  • Contate-nos

    E-mail: jacob@steroid-peptídeo.com

    WhatsApp: +8615636286252

    Telefone: 0086-15636286252

    Site: www.steroid-peptídeo.com

    Bem-vindo a sua pergunta

  • Serviço